# 119-hr-6321: Lung Cancer Medicare Access to Precise Testing Act

119-hr-6321, Lung Cancer Medicare Access to Precise Testing Act, is a 119th Congress bill sponsored by Rep. Gottheimer, Josh [D-NJ-5] (D-NJ); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-hr-6321
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-6321
- Congress: 119
- Title: Lung Cancer Medicare Access to Precise Testing Act
- Status: introduced
- Introduced: 2025-11-28
- Sponsor: Rep. Gottheimer, Josh [D-NJ-5] (D-NJ)
- Cosponsors: 3
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**This bill would require Medicare to cover lung cancer biomarker testing and pay 100% of the reasonable charges for those tests.** It defines covered testing as tests furnished on or after January 1, 2027 that identify one or more specific biomarkers, such as genes, proteins, or other molecules, from a patient's tissue, blood, or bodily fluids. - People on Medicare diagnosed with lung cancer would have biomarker testing covered when the test is furnished on or after January 1, 2027. - Labs and clinicians who provide these tests would receive Medicare payment equal to 100 percent of the reasonable charges for the covered lung cancer biomarker testing. - The bill sets a clear definition of covered lung cancer biomarker testing by listing the types of biomarkers and the sample sources that qualify for coverage, which narrows what services fall under the benefit.

## Cosponsors (3)

- Rep. Kiggans, Jennifer A. [R-VA-2] (R-VA), 2025-11-28T00:00:00.000Z
- Rep. Swalwell, Eric [D-CA-14] (D-CA), 2025-12-15T00:00:00.000Z
- Rep. Grijalva, Adelita S. [D-AZ-7] (D-AZ), 2026-02-03T00:00:00.000Z

## Provisions PRIA read

- Medicare would fully cover lung biomarker tests: benefit, high. If enacted, Medicare would cover lung cancer biomarker tests. Coverage would apply to tests given on or after January 1, 2027. The test would need to be for someone diagnosed with lung cancer and look for genes, proteins, or other markers in tissue, blood, or fluids. Medicare would pay 100% of the…

## Related bills

- 119-hr-9877: Health Equity and Accountability Act of 2026
- 119-hr-3151: SHIPS for America Act of 2025
- 119-hr-7973: Momnibus Act
- 119-hr-4669: FEMA Act of 2025
- 119-hr-4206: CONNECT for Health Act of 2025
- 119-hr-1004: Love Lives On Act of 2025

## Sources
- [119-hr-6321 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/6321)

## Related
- [119-hr-9877: Health Equity and Accountability Act of 2026](https://policyrisk.com/legislation/119-hr-9877)
- [119-hr-3151: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-hr-3151)
- [119-hr-7973: Momnibus Act](https://policyrisk.com/legislation/119-hr-7973)
- [119-hr-4669: FEMA Act of 2025](https://policyrisk.com/legislation/119-hr-4669)
- [119-hr-4206: CONNECT for Health Act of 2025](https://policyrisk.com/legislation/119-hr-4206)
- [119-hr-1004: Love Lives On Act of 2025](https://policyrisk.com/legislation/119-hr-1004)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-6321 (as of 2026-04-21).